HArmonyCa is designed for facial soft-tissue augmentation, but it is not simply used wherever you notice a line, hollow or area of looseness. Treatment focuses on specific areas where added support, improved contour and gradual skin quality changes may help create a balanced result. The treatment is commonly considered for the mid and lower face, with expert recommendations highlighting several lateral facial zones.
HArmonyCa combines hyaluronic acid (HA) and calcium hydroxyapatite (CaHA) in one hybrid injectable. The HA component provides an immediate volumising effect, while CaHA supports gradual collagen production and improvements in skin firmness. This dual action allows you to achieve both early support and longer-term improvements.
Treatment planning looks at the face as a whole rather than focusing on one isolated concern. Supporting one area may help improve overall facial balance, depending on your anatomy, skin quality and ageing pattern. The most suitable areas for you will be decided during consultation based on your individual goals and facial structure.
Understanding How HArmonyCa Treatment Areas Are Selected
HArmonyCa treatment areas are selected based on your facial anatomy rather than a standard template. During your consultation, your practitioner will assess where support has reduced, where tissues have become looser and how different areas of the face work together. This helps create a treatment plan that matches your individual structure and aesthetic goals.
Recent expert recommendations for HA-CaHA hybrid injectables highlight the importance of treating specific lateral and less mobile areas of the face. These may include the lateral cheek, preauricular region, submalar area, mandibular ramus and jawline. The exact areas considered will depend on your facial features, skin quality and the changes you would like to address.
This approach explains why HArmonyCa is not simply used to target every visible line or wrinkle. Instead, the treatment focuses on restoring support, improving soft-tissue positioning and enhancing overall facial balance. The areas that concern you most may not always be the only areas that need attention, as treating another region may help achieve a more harmonious result.
Why the Mid and Lower Face Are Important Treatment Regions
The official UK HArmonyCa information states that the treatment may help stimulate collagen production and provide lift in the mid and lower areas of the face. It also highlights use in areas such as the preauricular region and along the ascending and descending branches of the jaw.
These areas are important because facial ageing does not occur in separate sections. Changes in volume, soft-tissue position and skin firmness can affect how the cheeks, sides of the face and jawline appear together. Understanding these connections helps your practitioner create a more balanced approach based on your facial structure.
For example, reduced support in the lateral face may contribute to a heavier appearance in the lower face. When you consider HArmonyCa treatment, the focus is not only on individual concerns but also on how different areas influence overall facial harmony.
You may not need every possible treatment zone to be treated. A personalised plan should identify the most suitable areas for you, focusing on strategic support to help achieve your desired result.
| Treatment Area | Why It May Be Considered | Planning Consideration |
| Midface | Volume deficit and reduced structural support | Treatment depends on the pattern and severity of volume loss |
| Lateral cheek | Support and facial contour | Usually considered as part of wider facial balance |
| Preauricular area | Lateral facial support, volume and firmness | Supported by a small prospective clinical study |
| Submalar area | Transition between cheek and lower face | Should be assessed alongside surrounding structures |
| Mandibular ramus and angle | Lower-face structure and contour | Requires anatomy-based planning |
| Mandibular body and jawline | Facial outline and definition | Not every soft jawline is caused by volume loss |
| Lower face | Selected laxity and support concerns | May need a combined treatment approach in some patients |
The Midface
The midface is one of the key areas studied in clinical research involving HArmonyCa. Official UK information refers to a one-year prospective open-label post-marketing study involving patients with moderate to severe midface volume deficit, with outcomes assessed after treatment.
The midface contains important structural and soft-tissue areas that influence how supported, refreshed and balanced your face appears. Changes in this region can affect the relationship between the cheeks and the lower face, which is why treatment planning needs to consider overall facial harmony.
HArmonyCa may be considered when there is a suitable pattern of volume loss, tissue laxity or reduced support. The goal is not to create overly full cheeks but to enhance your natural features while maintaining a balanced appearance.
Your practitioner will assess whether HArmonyCa, another injectable or a combination approach is most appropriate for you. This decision will depend on your facial anatomy, concerns and the results you would like to achieve.
The Lateral Cheek
The lateral cheek is one of the preferred areas identified in global recommendations for facial rejuvenation using HA-CaHA hybrid injectables. Experts often highlight this outer cheek region when planning treatment for structural support and soft-tissue repositioning.
This area is located towards the outer part of the cheek rather than directly beside the nose. Supporting the lateral cheek may help improve the transition between the middle and outer areas of your face, creating a more balanced appearance.
When the lateral cheek loses support, you may notice reduced definition or a change in how the tissues sit. Treatment aims to improve support while maintaining a natural look rather than creating an overfilled appearance.
The amount and placement of HArmonyCa need to be personalised for you. Your cheek shape, facial proportions and underlying bone structure all play a role in deciding the most suitable treatment approach.
The Preauricular Area
The preauricular area, located in front of the ear, is an important HArmonyCa treatment zone. A 2023 prospective study cited by the official UK website assessed treatment in this region, looking at changes in volume, tissue properties and facial tension vectors during follow-up. Although this may not be the first area you think about when considering facial rejuvenation, it can play a role in improving the overall balance of the lateral face.
Supporting this area may help address changes in soft-tissue support and contribute to improved facial firmness and contour. The study reported changes in tissue density, viscoelasticity and firmness, with increased collagen observed in treated areas after 180 days. These findings should be interpreted carefully, as the study involved a small group of patients and was not a randomised trial.
Your treatment plan should always be personalised rather than based on a standard research approach. Your practitioner will assess your facial proportions, skin quality and degree of laxity to decide whether this area is suitable for you. A carefully planned approach helps ensure that treatment supports your natural features and works towards your individual goals.
Evidence Note:
Clinical research on HArmonyCa is growing, but the strength of evidence varies between treatment areas. The preauricular study included a small group of 15 patients and was prospective but non-randomised, while a larger prospective open-label study assessed treatment of midface volume deficit over 12 months. More recent expert recommendations combine published evidence with clinical experience to guide treatment-area selection. For you as a patient, this means treatment should still be based on individual anatomy and suitability rather than assuming that every researched facial zone is appropriate for everyone.
The Submalar Area
The submalar area is another preferred treatment region identified in recent expert recommendations. Located beneath the cheekbone, this area can influence the transition between the cheek and lower part of the face. Changes here may affect how supported and balanced your facial features appear over time.
When the submalar area loses support, you may notice a flatter or less defined appearance. If treatment is suitable, the aim is usually to improve structure and support rather than simply add noticeable volume. This approach helps maintain a natural result that complements your existing facial anatomy.
HArmonyCa treatment should be planned strategically to suit you rather than to create unnecessary changes. Your practitioner may assess the submalar region alongside areas such as the lateral cheek and preauricular area to create a more balanced approach. Treating connected facial zones can sometimes help achieve a smoother and more harmonious overall result.
The Cheeks as Part of a Wider Facial Plan
When you say you want your cheeks treated, this could mean several different concerns, such as flattening, loss of support, reduced firmness or changes in nearby areas. The cheeks are an important part of overall facial balance, so treatment planning needs to look beyond one specific area.
HArmonyCa treatment planning should consider the reason behind the change you are noticing. The product combines an immediate HA-related effect with a CaHA component designed to support collagen production over time. This allows your practitioner to consider both structural support and gradual improvements in tissue quality.
However, not every cheek hollow or contour concern will be best suited to HArmonyCa. Some patients may benefit from a traditional HA filler for more precise shaping, while others may be better suited to HArmonyCa in selected areas. The right approach for you depends on your facial anatomy, ageing pattern and the result you would like to achieve.
The Lower Face
The lower face is one of the main regions discussed in relation to HArmonyCa treatment. Official UK information states that the treatment may help create lift and encourage collagen production in the mid and lower facial areas. When you notice changes in this region, the cause may involve several different factors rather than one isolated concern.
Lower-face ageing can involve reduced definition, tissue laxity and changes in how the cheeks connect with the jawline. A suitable treatment plan looks at which changes are contributing to your concerns before deciding where support may be most beneficial. This helps avoid simply adding volume to areas that appear heavier.
HArmonyCa may be considered as part of a structural approach to lower-face rejuvenation. The most suitable injection zones for you will depend on your jaw anatomy, skin quality and overall facial proportions. A personalised plan aims to enhance balance while maintaining a natural-looking result.
The Mandibular Angle
The mandibular angle is located towards the back of the jaw, where the lower border changes direction towards the ear. Recent expert recommendations include this region among the preferred areas for HA-CaHA hybrid treatment. When you are considering lower-face rejuvenation, this area may be assessed as part of your overall facial structure.
Treatment in this region may help improve lower-face support and create a clearer transition between the face and jawline. The aesthetic goal should always be adapted to your natural anatomy and the type of result you would like to achieve. Some patients may want more definition, while others may simply want to restore changes caused by ageing.
The amount of product used requires careful planning to maintain balance. Good contouring should complement the rest of your face rather than make one area appear disconnected from the cheeks or chin. A personalised approach helps ensure the result looks natural and suits your existing features.
The Mandibular Body
The mandibular body is the longer section of the lower jaw that sits between the chin area and the angle of the jaw. It is included within the mandibular regions discussed in current expert recommendations for HA-CaHA hybrid injectables. When you are exploring lower-face treatment, this area may be considered as part of your overall facial assessment.
Loss of definition along the mandibular body can make the lower facial outline appear softer or less structured. Carefully planned treatment may help improve support and create a smoother contour in suitable patients. The aim is to enhance your natural jawline rather than add unnecessary volume.
However, not every change along the jawline is caused by reduced injectable support. Factors such as skin laxity, fat distribution, muscle activity and bone structure can all affect how your lower face appears. This is why your practitioner should assess you from different angles, both at rest and during movement, before creating a personalised treatment plan.
The Lateral Jawline and Facial Outline
The side of the jawline plays an important role in the overall outline of your face. When you look at your profile or three-quarter view, this area helps create the transition between the cheek, lower face and neck. Changes in support here can influence how defined or balanced your facial structure appears.
HArmonyCa may be used strategically along suitable parts of the jaw area as part of a wider lower-face treatment plan. The official UK information notes use in areas such as the preauricular region and the ascending and descending branches of the jaw. Your practitioner will consider whether these areas are appropriate based on your facial anatomy and goals.
The aim is usually to improve support, contour and firmness rather than simply make the jaw appear larger. Subtle refinement is often more suitable than dramatic augmentation, especially when you want a natural-looking result. Your cheek width, chin projection and jaw structure all need to work together to create a balanced facial outline.
The Jawline
The jawline is one of the facial areas commonly considered in structural treatment planning using HA-CaHA hybrid injectables. Expert recommendations include the mandibular region, such as the ramus, angle, body and jawline, as potential treatment zones. When you notice reduced definition in this area, it is important to understand the factors contributing to the change.
A less defined jawline can be linked to changes in soft-tissue support, skin laxity or shifts in facial contour. Treatment planning should identify the underlying cause rather than focusing only on the visible concern. This helps determine whether HArmonyCa is the most suitable option for you.
HArmonyCa may help improve support and definition in appropriate patients while maintaining a natural appearance. The goal is usually to enhance your existing lower-face structure rather than create an overly sharp or artificial jawline. Your bone structure, facial proportions and individual features all influence the best treatment approach.
Areas of Mild to Moderate Volume Loss
HArmonyCa is often considered for patients with mild to moderate volume loss, contour changes, and early skin laxity. The aim is to improve structural support and facial balance rather than simply add large amounts of volume. A personalised assessment is important because the pattern and cause of volume loss can vary significantly from one person to another.
1. Mild to Moderate Volume Loss: HArmonyCa may be suitable for areas with early volume depletion and subtle contour changes. The focus is on restoring support while maintaining a natural appearance.
2. Individualised Treatment Planning: Patients with widespread volume loss may need a different approach from those with deeper, localised hollows. Treatment should be based on your facial anatomy and specific concerns.
3. Immediate and Gradual Effects: The hyaluronic acid component provides an early supportive effect, while the calcium hydroxyapatite component encourages collagen production over time. This combination offers both short-term and progressive improvement.
4. When Alternative Treatments May Be Needed: More significant volume loss may require a different treatment or a combined approach. Your practitioner can discuss the most appropriate options during your consultation.
Overall, HArmonyCa is designed to address early to moderate changes in facial structure and skin quality. A personalised assessment helps ensure the treatment plan is tailored to your needs and supports balanced, natural-looking rejuvenation.
Areas Affected by Skin Laxity
Skin laxity is one of the concerns discussed in recent recommendations for HA-CaHA hybrid injectables. This approach may be considered for selected patients where improving structural support and soft-tissue positioning are suitable goals. If you notice changes such as looseness or reduced firmness, the cause needs to be assessed carefully.
Laxity does not always affect every part of the face in the same way. You may notice early changes in areas such as the lateral cheek, lower face or jawline, while other regions continue to have good support. Understanding these patterns helps your practitioner decide which areas may benefit most from treatment.
The goal is not to treat every area where looseness appears but to focus on regions where added support may create the best overall improvement. HArmonyCa can help in appropriate cases, but significant excess skin or advanced sagging may require other treatment options. A personalised assessment helps determine the most suitable approach for you and your facial needs.
Areas Where Loss of Firmness Is the Main Concern
Some patients are less focused on volume loss and more concerned that their facial tissues feel less firm than they used to. HArmonyCa is designed to combine an immediate HA-related effect with a CaHA component that supports collagen production over time. When you are looking to improve firmness, treatment planning needs to consider the underlying changes in your skin and soft tissues.
The official UK information describes observed increases in tissue density, viscoelasticity and firmness in a small prospective study following treatment of the preauricular region. Increased collagen in treated areas was also reported at the 180-day assessment. These findings suggest that some effects may develop gradually rather than appearing immediately.
Because of this, the results should not be judged only by what you see straight after treatment. Some tissue-related changes may continue to develop over the following months. The most suitable treatment area will still depend on your facial anatomy, as HArmonyCa should be placed strategically rather than used in an area that is not appropriate for your needs.
Why HArmonyCa Is Not Used Like a Filler for Every Line
One of the most important things to understand is that HArmonyCa is not designed to simply fill every facial line directly. Current expert recommendations focus on selected lateral and less mobile facial areas, with the aim of providing structural support and encouraging soft-tissue repositioning. When you consider HArmonyCa, the focus is usually on improving overall facial balance rather than treating every visible crease.
A line or wrinkle may appear because of different factors, including facial movement, volume loss, changes in skin quality or reduced support in nearby areas. This means treating the visible line alone may not always address the underlying cause. Your practitioner will assess what is contributing to the concern before deciding on the most suitable treatment approach.
This is especially important when comparing HArmonyCa with traditional HA fillers, as different injectables have different properties and purposes. The right choice depends on your facial anatomy, concerns and desired outcome. During consultation, your practitioner can help you understand whether HArmonyCa or another option is more appropriate for you.
Why Delicate and Highly Mobile Areas Need a Different Strategy
Recent expert recommendations advise using HA-CaHA hybrid injections in lateral and relatively less mobile areas of the face. This approach reflects the importance of matching the product and injection technique to the specific anatomy of the treatment area. When you consider treatment, understanding these differences can help set realistic expectations.
Very delicate or highly mobile facial areas often need a different approach. A product that works well in one region should not automatically be considered suitable for every other part of the face. Factors such as tissue thickness, movement and the type of concern all influence the most appropriate treatment choice.
Fine surface lines or areas requiring precise contouring may need a different injectable or another treatment option altogether. Your practitioner should explain why certain areas are suitable for HArmonyCa and why others may require a different strategy. This helps you make a more informed decision based on your individual facial needs.
Treating Several Connected Areas in One Plan
Facial ageing is a three-dimensional process, which is why assessing connected areas together can be beneficial. The cheek, preauricular region and jawline influence how your face appears as a whole, even though they are separate anatomical areas. When you consider HArmonyCa, looking at these relationships can help create a more balanced treatment approach.
Recent recommendations for the hybrid injectable highlight preferred zones such as the lateral cheek, preauricular area, submalar region and mandibular structures. This supports a strategic approach that considers overall facial structure rather than focusing only on one isolated concern.
You may not need every possible area to be treated, as the most effective plan depends on your individual features and goals. A thorough assessment helps identify where support may be beneficial and which areas do not require intervention. Good aesthetic planning is about creating harmony and achieving natural-looking results rather than using the maximum amount of product.
How Your Practitioner Decides Which Areas to Treat
Before recommending HArmonyCa, your practitioner should assess your medical history, facial anatomy, tissue quality and aesthetic goals. Choosing the right treatment areas is a personalised process, as the plan needs to match your facial structure rather than follow a standard approach. When you have a consultation, an experienced practitioner will help determine whether HArmonyCa is suitable for your concerns.
Your face should be assessed from different angles, including the front, side and oblique views. Some changes may not be obvious from one perspective but become clearer when your overall facial proportions are considered. This allows your practitioner to understand where support may be beneficial and where treatment may not be needed.
Your practitioner should also explain the expected benefits, limitations and possible side effects before treatment. Official UK information lists common short-term reactions such as redness, swelling, pain, tenderness and itching, with advice to seek guidance if symptoms continue or worsen. The consultation is also your chance to discuss your preferences, so the treatment plan can reflect the type of result you want to achieve while remaining realistic.
Safety and Suitability Note:
HArmonyCa is a medical injectable treatment and is not suitable for every person or every facial area. Before treatment, your practitioner should review your medical history, assess your facial anatomy and discuss relevant contraindications, expected side effects and potential complications. Treatment planning should follow the product instructions and use an appropriate technique for the selected anatomical area.
Choosing the Right HArmonyCa Treatment Areas for You
HArmonyCa may be considered for selected areas of the mid and lower face, with current recommendations focusing particularly on lateral facial zones. These areas may include the lateral cheek, preauricular region, submalar area and selected parts of the mandibular ramus and jawline. The most suitable areas for you will depend on your facial structure, skin quality and treatment goals.
The area where you first notice signs of ageing is not always the area that needs treatment. Visible changes may sometimes be linked to reduced support in another part of the face, which is why a full facial assessment is important before deciding where to inject. This helps create a plan that improves overall balance rather than focusing only on one concern.
It is also important to have realistic expectations about what HArmonyCa can achieve. The treatment combines an immediate HA-related supportive effect with gradual CaHA-associated collagen stimulation, but results vary between individuals. Your practitioner will tailor the approach to your anatomy and help you understand whether HArmonyCa is the right option for you.
Key Takeaways:
1. HArmonyCa is intended for facial soft-tissue augmentation in selected facial regions rather than for treating every line or wrinkle.
2. Treatment planning should be based on your anatomy, facial proportions, skin quality and aesthetic goals.
3. Current recommendations focus particularly on lateral cheek, preauricular, submalar and mandibular treatment zones.
4. The midface has also been studied in prospective clinical research.
5. HArmonyCa combines an early HA-related volumising effect with CaHA-associated collagen stimulation.
6. The preauricular study reported changes in volume, tension vectors and tissue properties, but it involved only 15 participants.
7. HArmonyCa is contraindicated for injection into periocular, glabellar, lip and perioral areas.
8. Not every jawline or cheek concern is caused by volume loss, so alternative or combined treatment approaches may sometimes be more suitable.
9. Results and treatment areas vary between individuals, making consultation and full facial assessment essential.
FAQs:
1. Which areas of the face can HArmonyCa treat?
HArmonyCa is commonly considered for selected areas of the mid and lower face where support, firmness and facial balance may be improved. Treatment areas may include the lateral cheek, preauricular region (in front of the ear), submalar area, mandibular region and parts of the jawline. The most suitable areas for you will depend on your facial anatomy, skin quality and aesthetic goals.
2. Can HArmonyCa be used to treat cheek volume loss?
Yes, HArmonyCa may be considered for certain types of cheek volume loss, particularly where structural support has reduced. The treatment is not designed to create overly full cheeks but aims to restore balance by providing support and encouraging gradual improvements in tissue quality.
3. Is HArmonyCa suitable for the jawline?
HArmonyCa may be used in selected areas of the lower face, including parts of the jawline and mandibular region. Your practitioner will assess your facial structure to determine whether this approach is suitable, as jawline concerns can be caused by different factors such as skin laxity, soft-tissue changes or natural anatomy.
4. Can HArmonyCa treat wrinkles and fine lines directly?
HArmonyCa is not designed to be injected into every facial line or wrinkle. Instead, it focuses on improving underlying support, soft-tissue positioning and skin quality in suitable areas. If fine lines are caused by other factors, your practitioner may recommend a different treatment approach.
5. What is the best area to have HArmonyCa treatment?
There is no single “best” HArmonyCa treatment area because everyone’s facial anatomy and ageing pattern are different. The most suitable area for you will be determined during consultation after assessing your facial structure, concerns and the type of result you would like to achieve.
6. Can HArmonyCa improve skin firmness?
HArmonyCa may help improve skin firmness over time because its calcium hydroxyapatite (CaHA) component is associated with collagen stimulation. However, results develop gradually, and the areas treated will depend on where improvements in support and tissue quality are most appropriate for you.
7. Can HArmonyCa be used under the eyes or around the lips?
No. HArmonyCa is contraindicated for injection into the periocular area, lips and perioral region. It is also contraindicated for injection into the glabellar area between the eyebrows. These regions require different treatment strategies because of their anatomy, tissue characteristics and product-specific safety considerations. Your practitioner can assess your concern and recommend a more appropriate treatment option.
8. Can more than one area be treated with HArmonyCa during the same plan?
Yes, some treatment plans may involve more than one connected facial area, such as the cheeks, preauricular region and jawline. Looking at these areas together can help create a more balanced result, but you may not need every possible treatment zone to achieve your goals.
9. How does a practitioner decide where to inject HArmonyCa?
Your practitioner will consider factors such as your facial proportions, bone structure, skin quality, tissue laxity and your aesthetic goals. A full facial assessment helps identify areas where support may improve balance while avoiding unnecessary treatment.
10. How long does it take to see results after HArmonyCa treatment?
You may notice an initial improvement from the hyaluronic acid (HA) component soon after treatment, while collagen-related changes from the calcium hydroxyapatite (CaHA) component develop gradually over the following months. The final outcome varies depending on your individual response and the areas treated.
Final Thoughts: Personalising Your HArmonyCa Treatment Plan
Choosing the right HArmonyCa treatment areas is an important part of achieving natural-looking facial rejuvenation. Rather than focusing only on the areas where you notice visible changes, a personalised assessment can help identify where support, improved contour and gradual skin quality improvements may be most beneficial for you.
HArmonyCa is designed to work strategically in selected areas of the mid and lower face, helping to address concerns such as reduced support, mild volume loss and changes in firmness. The best treatment plan will depend on your facial anatomy, skin quality and the results you would like to achieve. If you’re looking for HArmonyCa treatment in London, you can get in touch with us at the London Medical & Aesthetic Clinic.
References:
1. Cavallini, M. et al. (2025) Global Recommendations for Facial Rejuvenation Using a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable, Journal of Cosmetic Dermatology, 25(1), e70608. Available at: https://pubmed.ncbi.nlm.nih.gov/41566538/
2. Gritti, A. et al. (2025) A Prospective, Open-Label, Post Marketing Study of the Safety and Effectiveness of a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable, Journal of Cosmetic Dermatology, 24(9), e70430. Available at: https://pubmed.ncbi.nlm.nih.gov/40948024/
3. Bravo, B., Carvalho, R., Bravo, L., Penedo, L. and Elias, M. (2024) Blending Hyaluronic Acid and Calcium Hydroxylapatite for Injectable Facial Dermal Fillers: A Clinical and Ultrasonography Assessment, Cosmetics, 11(2), 61. Available at: https://www.mdpi.com/2079-9284/11/2/61
4. Yag-Howard, C. and DeNigris, J. (2021) Novel filler technique: Hyaluronic acid and calcium hydroxylapatite mixture resulting in favorable esthetic and longevity outcomes, International Journal of Women’s Dermatology, 7(5), pp. 817–819. Available at: https://www.sciencedirect.com/science/article/pii/S2352647521001167
5. Aguilera, S.B., McCarthy, A., Khalifian, S., Lorenc, Z.P., Goldie, K. and Chernoff, W.G. (2023) The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment: A Narrative Review, Aesthetic Surgery Journal, 43(10), pp. 1063–1090. Available at: https://academic.oup.com/asj/article/43/10/1063/7249933
